5 trends tracked about this subject — the full history, oldest to newest below.
Anthropic is aggressively entering the biopharma sector through a 100-day sprint involving Nobel laureates, M&A activity, and new scientific AI tools.
Anthropic is entering the biotech sector with Claude Science, a new research workbench designed for drug discovery and studying overlooked diseases.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Anthropic has entered the drug discovery sector with the launch of a dedicated AI research workbench and the development of internal pre-clinical trials.
Anthropic has released Claude Sonnet 5, a new AI model designed to support everyday agent tasks while offering cost-efficiency and reduced cyber risk.